Activity Info

This initiative is designed to close critical knowledge and competence gaps in pulmonary hypertension associated with interstitial lung disease (PH-ILD)—empowering clinicians to recognize disease earlier, screen proactively, and act decisively. By addressing disease progression, declining functional capacity, and quality-of-life impact, the program promotes coordinated multidisciplinary care and equips providers with the latest evidence-based strategies aligned to current clinical data and guidelines—ultimately improving outcomes in this high-risk population.